NASDAQ Global Market • Healthcare • Biotechnology • US • USD
Avidity Biosciences Inc (RNAM) has an overall financial health rating of C- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2026-02-27.
Be the first to know when stocks drop below their intrinsic value.
